Skip to main content

Testing for Malignant Hyperthermia in North America and Australia

  • Conference paper
Malignant Hyperthermia
  • 78 Accesses

Abstract

There are 14 biopsy centers for malignant hyperthermia (MH) in the United States and Canada, and 3 in Australia. In recent years 3 biopsy centers in North America have closed for funding reasons or because the center director changed the emphasis of his/her activities.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Larach MG (1989) Standardization of the caffeine halothane muscle contracture test. Anesth Analg 69: 511–515

    Article  PubMed  CAS  Google Scholar 

  2. Larach MH, Localio R, Allen GC, et al (1994) A clinical grading scale to predict malignant hyperthermia susceptibility. Anesthesiology 80: 771

    Article  PubMed  CAS  Google Scholar 

  3. Larach MG, Landis JR, Bunn JS, et al (1992) Prediction of malignant hyperthermia susceptibility in low-risk subjects. An epidemiologic investigation of caffeine halothane contracture rsponses. Anesthesiology 76: 16–24

    Article  PubMed  CAS  Google Scholar 

  4. Larach MG, Landis JR, Shirk SI, et al (1992) Prediction of malignant hyperthermia susceptibility in man: improving sensitivity of the caffeine halothane contracture test. Anesthesiology 77: A1052

    Article  Google Scholar 

  5. Wedel DJ, Nelson TE (1994) Malignant hyperthermia-diagnostic dilemma: False-negative contracture responses with halothane and caffeine alone. Anesth Analg 78: 787–785

    Google Scholar 

  6. O’Flynn RP, Shutack JG, Rosenberg H, et al (1994) Masseter muscle rigidity and malignant hyperthermia susceptibility in pediatric patients. Anesthesiology 80: 1228–1295

    Article  PubMed  Google Scholar 

  7. Wappler F, Roewer N, Lenzen C, et al (1994) High-purity ryanodine and 9,21dehydroryanodine for in vitro diagnosis of malignant hyperthermia in man. Br J Anaesth 72: 240–242

    Article  PubMed  CAS  Google Scholar 

Further Reading

  • Fletcher JE (1994) Current laboratory methods for the diagnosis of malignant hyperthermia susceptibility. In: Levitt RC (ed) Temperature regulation during anesthesia. Anesthesiology clinics of North America, vol. 12. Saunders, Philadelphia, pp 553–570

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag Tokyo

About this paper

Cite this paper

Rosenberg, H. (1996). Testing for Malignant Hyperthermia in North America and Australia. In: Morio, M., Kikuchi, H., Yuge, O. (eds) Malignant Hyperthermia. Springer, Tokyo. https://doi.org/10.1007/978-4-431-68346-9_8

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-68346-9_8

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-68348-3

  • Online ISBN: 978-4-431-68346-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics